GlassScriptPhysician profile
Paul M Heimbecker
NPI 1396719266
$2,788.61
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.41 · 2020: $11.24 · 2021: $61.94 · 2022: $523 · 2023: $860 · 2024: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,228.04 |
| Travel and Lodging | $909.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,221.57 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $102.67 | 2022-2024 | Veozah |
| Pfizer INC. | $85.78 | 2023-2024 | |
| Coopersurgical, INC. | $62.26 | 2024 | Endosee |
| Organon LLC | $55.29 | 2023-2024 | Jada System |
| Sumitomo Pharma America, INC. | $43.50 | 2024 | Gemtesa, Myfembree |
| Ethicon US, LLC | $38.60 | 2019 | |
| Hologic Sales and Service, LLC | $38.07 | 2023-2024 | Acessa Provu System, Novasure |
| Minerva Surgical, INC | $22.01 | 2021 | |
| Conmed Corporation | $18.65 | 2024 | Airseal |
| Abbvie INC. | $16.81 | 2019 | |
| Novo Nordisk INC | $16.32 | 2023 | Saxenda, Wegovy |
| Aspira Women'S Health INC | $15.03 | 2024 | Ova1 |
| Avation Medical, INC. | $14.92 | 2024 | Vivally |
| Exeltis, USA INC. | $13.17 | 2024 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $12.72 | 2023 | Balcoltra |
| Allergan, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Heimbecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.